73  Total SME IPOs listed in 2025

3,196.85 Crs.  Total funds raised in 2025

49  SME IPOs listed with Gain in 2025

24  SME IPOs listed with loss in 2025

73  Total SME IPOs listed in 2025

3196.85 Crs.  Total funds raised in 2025

49  SME IPOs listed with Gain in 2025

24  SME IPOs listed with loss in 2025

73  Total SME IPOs listed in 2025

3196.85 Crs.  Total funds raised in 2025

49  SME IPOs listed with Gain in 2025

24  SME IPOs listed with loss in 2025

73  Total SME IPOs listed in 2025

3196.85 Crs.  Total funds raised in 2025

49  SME IPOs listed with Gain in 2025

24  SME IPOs listed with loss in 2025

Ganga Pharmaceuticals IPO (Ganga Pharmaceuticals Limited IPO) Detail

Ganga Pharmaceuticals Limited is an Pharmaceutical - Ayurvedic based company, located in Mumbai, Ganga Pharmaceuticals Limited IPO size was 1.54 Cr. and was issued at 15.00 per share. The share of Ganga Pharmaceuticals Limited were listed at 14.50 per share and are currently trading at 14.80 per share.

Type :
Sub Sector : Marketing Distribution Of Bulk Ayurvedic Medicines
SME IPO
BSE SME

Financial Summary (at the time of ipo, on annualised basis)

Revenue :
2.58 Cr.

PAT :
0.09 Cr.

Pricing Report

Issue Price :
15.00

Listing Price :
14.50

Current Market Price :
14.80

Issue Price vs CMP :
0.2 (1.33%)

listing Price vs CMP :
0.3 (2.07%)

Performance Report (CAGR* wise)

CAGR : -0.14
-ve 0 6 9 12+
Below Average

*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.

*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.

About Ganga Pharmaceuticals

Company Information
Ganga Pharmaceuticals Limited was founded in 1974 by the visionary Late Shri Brijmohan Sharma, a qualified Ayurveda expert, as a proprietary concern. In 1989, the proprietary firm was converted into a private limited company, and later, on 19th September 1994, it became a public limited company. Initially, the company was established as a producer of quality bulk Ayurvedic medicines in Mumbai. In addition to manufacturing, the company is also involved in the marketing and distribution of bulk Ayurvedic medicines.

Under the management of Late Shri Brijmohan Sharma, the company built a remarkable market reputation, not just in Mumbai, but across Maharashtra. The company initially manufactured proprietary products such as Ampachan Vati, Khadira Vati, and Nirmalaya Churna. Recognizing the growing demand for these products and the increasing
Show More
Object of Issue
  • Enhance Company

Ganga Pharmaceuticals SME IPO Details (at the time of IPO)

IPO Type :
Fixed Price
IPO Date :
Feb, 2016
IPO Size :
1.54 Cr.
PE Multiple :
65.00
Anchor Investors:
Thinking of
Listing Your Business through
SME IPO?
We can Help!
Contact Us Today

See Other SME IPOs in Mumbai

3B FILMS LIMITED

  manufacturing and supplying of Cast Polypropylene (CPP) and Cast Polyethylene (CPE) films

  Vadodara


Neptune Petrochemicals Limited

  Manufacturing and trading of a comprehensive range of bitumen products, bitumen emulsions and allied products

  Ahmedabad


NR Vandana Tex Industries Limited

  design, manufacturing, and wholesale distribution of cotton textile products, including sarees, salwar suits, and bed sheets.

  Kolkata


Nikita Papers Limited

  manufacturing of paper and paper products.

  New Delhi


Astonea Labs Limited

  contract manufacturing of pharmaceutical and cosmetic products

  Chandigarh


Peer Companies Of This Sector

FAQs

Ganga Pharmaceuticals operates in Pharmaceutical - Ayurvedic and Marketing Distribution Of Bulk Ayurvedic Medicines. The Issue is listed on BSE SME in Feb, 2016. Ganga Pharmaceuticals IPO size was 1.54 Cr. with Issue price of 15.00 .

Ganga Pharmaceuticals IPO subscription was 0.00 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.

Ganga Pharmaceuticals IPO listed at a listing price of 14.50 against the offer price of 15.00.

The current market price of Ganga Pharmaceuticals is 14.80.

Services

IPO Advisory
IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Readiness
IPO Readiness
IPO Roadmap by improving Business Efficiencies, Financial Parameters and Corporate Structure to become IPO ready.
Fund Raising
Fund Raising
Fuelling a company's growth through Pre IPO Fund Raise, Private Equity, and Angel Investing.
SME : Business Scaling
SME Business Upscaling
Provide support to build a scalable SME business by unleashing the SME potential.
Post IPO Montoring
Post IPO Mentoring
Assisting with post IPO regulatory requirements and Performance Monitoring to achieve the milestone of Mainboard migration.

Thinking of
Listing Your Business through SME IPO?

We can help! Contact Us

Why Us?

  • Leading portal for IPOs
  • End to End Solutions
  • Known for Transparency